Trial Profile
Effect of reduced cholinergic transmission by rocuronium on the hypoxic ventilatory response in patients with obstructive sleep apnea - before and after three months of continous positive airway pressure treatment. A non-radomised, non-blinded study.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 01 Nov 2012
Price :
$35
*
At a glance
- Drugs Rocuronium bromide (Primary)
- Indications Sleep apnoea syndrome
- Focus Pharmacodynamics
- 05 Mar 2012 New trial record